211 related articles for article (PubMed ID: 17445209)
1. Influence of inhibitory killer immunoglobulin-like receptors and their HLA-C ligands on resolving hepatitis C virus infection.
Rauch A; Laird R; McKinnon E; Telenti A; Furrer H; Weber R; Smillie D; Gaudieri S;
Tissue Antigens; 2007 Apr; 69 Suppl 1():237-40. PubMed ID: 17445209
[TBL] [Abstract][Full Text] [Related]
2. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
3. Association of killer immunoglobulin-like receptors and their HLA Class I ligands with progression of chronic hepatitis C virus infection.
López-Vázquez A; Rodrigo L; López-Larrea C
Tissue Antigens; 2007 Apr; 69 Suppl 1():241-2. PubMed ID: 17445210
[TBL] [Abstract][Full Text] [Related]
4. Immunology. NK cells lose their inhibition.
Parham P
Science; 2004 Aug; 305(5685):786-7. PubMed ID: 15297654
[No Abstract] [Full Text] [Related]
5. KIR genes and their human leukocyte antigen ligands in the progression to cirrhosis in patients with chronic hepatitis C.
Marangon AV; Silva GF; de Moraes CF; Grotto RM; Pardini MI; de Pauli DS; Sell AM; Visentainer JE; Moliterno RA
Hum Immunol; 2011 Nov; 72(11):1074-8. PubMed ID: 21920398
[TBL] [Abstract][Full Text] [Related]
6. Associations between KIR epitope combinations expressed by HLA-B/-C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses.
Gaudieri S; Nolan D; McKinnon E; Witt CS; Mallal S; Christiansen FT
Mol Immunol; 2005 Feb; 42(4):557-60. PubMed ID: 15607813
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection.
López-Vázquez A; Rodrigo L; Martínez-Borra J; Pérez R; Rodríguez M; Fdez-Morera JL; Fuentes D; Rodríguez-Rodero S; Gonzáez S; López-Larrea C
J Infect Dis; 2005 Jul; 192(1):162-5. PubMed ID: 15942906
[TBL] [Abstract][Full Text] [Related]
8. Increased frequencies of activating natural killer receptors are associated with liver injury in individuals who do not eliminate hepatitis C virus.
Paladino N; Flores AC; Marcos CY; Fainboim H; Theiler G; Arruvito L; Williams F; Middleton D; Fainboim L
Tissue Antigens; 2007 Apr; 69 Suppl 1():109-11. PubMed ID: 17445180
[TBL] [Abstract][Full Text] [Related]
9. Killer cell immunoglobulin-like receptors and response to antiviral treatment in Thai patients with chronic hepatitis C virus genotype 3a.
Vejbaesya S; Nonnoi Y; Tanwandee T; Srinak D
J Med Virol; 2011 Oct; 83(10):1733-7. PubMed ID: 21755501
[TBL] [Abstract][Full Text] [Related]
10. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.
Khakoo SI; Thio CL; Martin MP; Brooks CR; Gao X; Astemborski J; Cheng J; Goedert JJ; Vlahov D; Hilgartner M; Cox S; Little AM; Alexander GJ; Cramp ME; O'Brien SJ; Rosenberg WM; Thomas DL; Carrington M
Science; 2004 Aug; 305(5685):872-4. PubMed ID: 15297676
[TBL] [Abstract][Full Text] [Related]
11. Impact of the genetic restriction of virus-specific T-cell responses in hepatitis C virus infection.
Neumann-Haefelin C; Thimme R
Genes Immun; 2007 Apr; 8(3):181-92. PubMed ID: 17230195
[TBL] [Abstract][Full Text] [Related]
12. Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma.
Naumova E; Mihaylova A; Ivanova M; Mihailova S
Cancer Immunol Immunother; 2007 Jan; 56(1):95-100. PubMed ID: 16547704
[TBL] [Abstract][Full Text] [Related]
13. HLA-C/KIR genotypes in oral lichen planus patients infected or non-infected with hepatitis C virus.
Carrozzo M; Elia A; Mereu V; Dametto E; Fasano M; Broccoletti R; Rendine S; Amoroso A
Oral Dis; 2011 Apr; 17(3):309-13. PubMed ID: 20860769
[TBL] [Abstract][Full Text] [Related]
14. HLA-C and KIR genes in hepatitis C virus infection.
Montes-Cano MA; Caro-Oleas JL; Romero-Gómez M; Diago M; Andrade R; Carmona I; Aguilar Reina J; Núñez-Roldán A; González-Escribano MF
Hum Immunol; 2005 Nov; 66(11):1106-9. PubMed ID: 16571411
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component.
Hsu KC; Pinto-Agnello C; Gooley T; Malkki M; Dupont B; Petersdorf EW
Tissue Antigens; 2007 Apr; 69 Suppl 1():42-5. PubMed ID: 17445161
[TBL] [Abstract][Full Text] [Related]
16. Receptor systems controlling natural killer cell function are genetically stratified in Europe.
Guinan KJ; Cunningham RT; Meenagh A; Dring MM; Middleton D; Gardiner CM
Genes Immun; 2010 Jan; 11(1):67-78. PubMed ID: 19693090
[TBL] [Abstract][Full Text] [Related]
17. NK cells prevalence, subsets and function in viral hepatitis C.
Zeromski J; Mozer-Lisewska I; Kaczmarek M; Kowala-Piaskowska A; Sikora J
Arch Immunol Ther Exp (Warsz); 2011 Dec; 59(6):449-55. PubMed ID: 21972016
[TBL] [Abstract][Full Text] [Related]
18. Role of a KIR/HLA-C allorecognition system in pregnancy.
Varla-Leftherioti M
J Reprod Immunol; 2004 Jun; 62(1-2):19-27. PubMed ID: 15288178
[TBL] [Abstract][Full Text] [Related]
19. Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma.
Butsch Kovacic M; Martin M; Gao X; Fuksenko T; Chen CJ; Cheng YJ; Chen JY; Apple R; Hildesheim A; Carrington M
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2673-7. PubMed ID: 16284396
[TBL] [Abstract][Full Text] [Related]
20. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
